MAMU
Marathon Asset Management (UK)’s Royalty Pharma RPRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $20.9M | Sell |
579,621
-66,625
| -10% | -$2.4M | 0.67% | 45 |
|
|
2025
Q1 | $20.1M | Sell |
646,246
-68,924
| -10% | -$2.15M | 0.61% | 46 |
|
|
2024
Q4 | $18.2M | Sell |
715,170
-46,981
| -6% | -$1.2M | 0.51% | 53 |
|
|
2024
Q3 | $21.6M | Buy |
762,151
+18,424
| +2% | +$521K | 0.6% | 51 |
|
|
2024
Q2 | $19.6M | Sell |
743,727
-48,680
| -6% | -$1.28M | 0.61% | 55 |
|
|
2024
Q1 | $24.1M | Sell |
792,407
-60,011
| -7% | -$1.82M | 0.64% | 55 |
|
|
2023
Q4 | $23.9M | Buy |
852,418
+86,585
| +11% | +$2.43M | 0.67% | 58 |
|
|
2023
Q3 | $20.8M | Sell |
765,833
-37,334
| -5% | -$1.01M | 0.65% | 59 |
|
|
2023
Q2 | $24.7M | Sell |
803,167
-90,025
| -10% | -$2.77M | 0.69% | 56 |
|
|
2023
Q1 | $32.2M | Sell |
893,192
-138,077
| -13% | -$4.97M | 0.9% | 46 |
|
|
2022
Q4 | $40.8M | Sell |
1,031,269
-42,476
| -4% | -$1.68M | 1.1% | 33 |
|
|
2022
Q3 | $43.1M | Sell |
1,073,745
-891,591
| -45% | -$35.8M | 1.29% | 30 |
|
|
2022
Q2 | $82.6M | Sell |
1,965,336
-111,392
| -5% | -$4.68M | 1.38% | 24 |
|
|
2022
Q1 | $80.9M | Sell |
2,076,728
-165,602
| -7% | -$6.45M | 1.1% | 39 |
|
|
2021
Q4 | $89.4M | Buy |
+2,242,330
| New | +$89.4M | 1.11% | 39 |
|